Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With MET Overexpression as a Second-line Treatment
Clinical trial NCT02447380 · COMPLETED
Trial details
- NCT number
- NCT02447380
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2019-02-18
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.